# Question 23

**Type:** Treatment Response

**Question:** Which genomic alterations are associated with immunotherapy response in melanoma patients from the MSK-CHORD Study?

**Answer:**

I'll help you analyze genomic alterations associated with immunotherapy response in melanoma patients from the MSK-CHORD study. Let me start by exploring the available data.



Calling `get_study_guide` with args:
```json
{
  "study_id": "msk_chord_2024"
}
```



Result from `get_study_guide`:
```json
# MSK-CHORD (MSK, Nature 2024)

**Study ID:** `msk_chord_2024`

## Overview
Targeted sequencing via MSK-IMPACT panels. Clinical annotations include some derived from natural language processing (denoted NLP).

## Gene Panels
This study uses multiple MSK-IMPACT panel versions:
- **IMPACT341**: Earlier version, 341 genes
- **IMPACT410**: 410 genes
- **IMPACT468**: 468 genes  
- **IMPACT505**: Latest version, 505 genes

**Important:** Different samples may have different gene coverage. Always use gene-specific denominators when calculating mutation frequencies.

## Clinical Attributes - Semantic Guide

### Cancer Classification
| Attribute | Description | Values |
|-----------|-------------|--------|
| `CANCER_TYPE` | Broad cancer category | e.g., "Non-Small Cell Lung Cancer", "Breast Cancer" |
| `CANCER_TYPE_DETAILED` | Specific subtype | e.g., "Lung Adenocarcinoma", "Invasive Ductal Carcinoma" |
| `ONCOTREE_CODE` | OncoTree classification code | Standardized cancer type codes |

### Sample Information
| Attribute | Description | Values |
|-----------|-------------|--------|
| `SAMPLE_TYPE` | Sample origin | Primary, Metastasis, Local Recurrence, Unknown |
| `SAMPLE_CLASS` | Sample classification | Tumor, Normal |
| `PRIMARY_SITE` | Anatomical primary site | e.g., Lung, Breast, Colon |
| `METASTATIC_SITE` | Site of metastasis (if applicable) | e.g., Liver, Bone, Brain |

### Genomic Features
| Attribute | Description | Notes |
|-----------|-------------|-------|
| `TMB_NONSYNONYMOUS` | Tumor mutational burden | Nonsynonymous mutations per Mb |
| `MUTATION_COUNT` | Total mutation count | Raw count of mutations in sample |
| `MSI_SCORE` | Microsatellite instability score | Numeric score |
| `MSI_TYPE` | MSI classification | Stable, Instable, Indeterminate |

### Clinical Groupings
| Attribute | Description | Notes |
|-----------|-------------|-------|
| `CLINICAL_GROUP` | Clinical grouping | Study-specific grouping |
| `PATHOLOGICAL_GROUP` | Pathological grouping | Study-specific grouping |
| `CLINICAL_SUMMARY` | NLP-derived clinical summary | May contain extracted clinical info |

### Prostate-Specific
| Attribute | Description |
|-----------|-------------|
| `GLEASON_SAMPLE_LEVEL` | Gleason score at sample level |
| `GLEASON_FIRST_REPORTED` | First reported Gleason score |
| `GLEASON_HIGHEST_REPORTED` | Highest reported Gleason score |

### Biomarkers
| Attribute | Description |
|-----------|-------------|
| `PDL1_POSITIVE` | PD-L1 expression status |
| `HISTORY_OF_PDL1` | History of PD-L1 testing |
| `HER2` | HER2 status (breast cancer) |
| `HR` | Hormone receptor status |

## Treatment Data

MSK-CHORD has **detailed treatment data** stored in clinical_event tables. This is one of the most comprehensive treatment datasets in cBioPortal.

### Treatment Event Keys

| Key | Description | Example Values |
|-----|-------------|----------------|
| `AGENT` | Drug/treatment name | FLUOROURACIL, PEMBROLIZUMAB, OXALIPLATIN |
| `SUBTYPE` | Treatment category | Chemo, Immuno, Targeted, Hormone, Radiation Therapy |
| `RX_INVESTIGATIVE` | Investigational drug flag | Y, N |
| `FLAG_OROTOPICAL` | Oral/topical administration | 0, 1 |
| `TREATMENT_TYPE` | Broad treatment type | Medical Therapy |
| `PRIOR_MED_TO_MSK` | Prior medications flag | Indicates meds before MSK care |
| `INFERRED_TX_PROB` | NLP inference probability | Confidence score for NLP-extracted data |

### Treatment Subtypes

| Subtype | Description |
|---------|-------------|
| `Chemo` | Cytotoxic chemotherapy |
| `Targeted` | Molecularly targeted agents (TKIs, etc.) |
| `Immuno` | Immunotherapy (checkpoint inhibitors, etc.) |
| `Hormone` | Hormonal therapy |
| `Radiation Therapy` | Radiation treatment |
| `Biologic` | Biologic agents |
| `Investigational` | Investigational/trial drugs |
| `Bone Treatment` | Bone-targeted agents (bisphosphonates, etc.) |
| `Prior Medications to MSK` | Medications before MSK treatment |

### Query Examples

```sql
-- Get treatments by subtype
SELECT 
    subtype.value as treatment_type,
    agent.value as agent,
    COUNT(DISTINCT ce.patient_id) as patients
FROM clinical_event ce
JOIN clinical_event_data agent ON ce.clinical_event_id = agent.clinical_event_id AND agent.key = 'AGENT'
JOIN clinical_event_data subtype ON ce.clinical_event_id = subtype.clinical_event_id AND subtype.key = 'SUBTYPE'
JOIN patient p ON ce.patient_id = p.internal_id
JOIN cancer_study cs ON p.cancer_study_id = cs.cancer_study_id
WHERE cs.cancer_study_identifier = 'msk_chord_2024'
  AND ce.event_type IN ('Treatment', 'TREATMENT')
GROUP BY subtype.value, agent.value
ORDER BY treatment_type, patients DESC;
```

### Treatment Data Caveats
- Some treatment data is NLP-extracted (`INFERRED_TX_PROB` indicates confidence)
- `PRIOR_MED_TO_MSK` captures pre-MSK treatments separately
- Treatment timing (start_date, stop_date) is in days from diagnosis

## Notes & Caveats
- Some clinical annotations are NLP-derived and may have extraction errors
- Multiple IMPACT panel versions mean gene coverage varies by sample
- Data is under CC BY-NC-ND 4.0 license; contact datarequests@mskcc.org for commercial use

```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_name\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name LIKE '%RESPONSE%' OR attribute_name LIKE '%BENEFIT%' OR attribute_name LIKE '%IMMUNO%'\nORDER BY attribute_name\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attribute_name":"ADC+IMMUNOTHERAPY"},{"attribute_name":"ADJUVANT_IMMUNOTHERAPY"},{"attribute_name":"ANY_LINE_IMMUNO"},{"attribute_name":"BEST_RESPONSE_ADC_AND_IMMUNOTHERAPY"},{"attribute_name":"BEST_RESPONSE_CHEMOTHERAPY_AND_IMMUNOTHERAPY"},{"attribute_name":"BEST_RESPONSE_IMMUNOTHERAPY"},{"attribute_name":"CHEMOTHERAPY+IMMUNOTHERAPY"},{"attribute_name":"CLINICAL_BENEFIT"},{"attribute_name":"DURABLE_CLINICAL_BENEFIT"},{"attribute_name":"HISTORY_IMMUNOLOGICAL_DISEASE"},{"attribute_name":"HISTORY_IMMUNOLOGICAL_DISEASE_OTHER"},{"attribute_name":"HISTORY_IMMUNOSUPPRESIVE_DX"},{"attribute_name":"HISTORY_IMMUNOSUPPRESIVE_DX_OTHER"},{"attribute_name":"HISTORY_IMMUNOSUPPRESSIVE_DISEASE"},{"attribute_name":"HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER"},{"attribute_name":"ICI_DURABLE_CLINICAL_BENEFIT"},{"attribute_name":"IMMUNOHISTOCHEMISTRY"},{"attribute_name":"IMMUNOPHENOTYPIC_ANALYSIS_METHOD"},{"attribute_name":"IMMUNOPHENOTYPIC_ANALYSIS_RESULTS"},{"attribute_name":"IMMUNOPHENOTYPIC_ANALYSIS_TESTED"},{"attribute_name":"IMMUNOSUPPRESSION"},{"attribute_name":"IMMUNOTHERAPY"},{"attribute_name":"IMMUNOTHERAPY_RESPONSE"},{"attribute_name":"IMMUNO_SUPPRESSIVE_TREATMENT"},{"attribute_name":"IMMUNO_SURVIVAL"},{"attribute_name":"LINE_OBR_IMMUNO"},{"attribute_name":"LINE_OBR_IMMUNO_G"},{"attribute_name":"NEOADJUVANT_IMMUNOTHERAPY"},{"attribute_name":"NUM_LINES_IMMUNO"},{"attribute_name":"OTHER_IMMUNOSUPPRESSIVE_DISEASE"},{"attribute_name":"POST_SAMPLE_IMMUNOTHERAPY"},{"attribute_name":"PRE_SAMPLE_IMMUNOTHERAPY"},{"attribute_name":"SURFACE_ANTIGENS_IMMUNOHISTOCHEMICAL_STAINS"},{"attribute_name":"TIDE_NO_BENEFITS"}]}
```


Great! I can see there are several immunotherapy response-related attributes. Let me now check for melanoma patients and their genomic alterations associated with immunotherapy response.



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE'\n  AND attribute_value LIKE '%Melanoma%'\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'IMMUNOTHERAPY_RESPONSE'\nORDER BY attribute_value\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check the cancer types more broadly and the response attributes:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE_DETAILED'\n  AND (attribute_value LIKE '%Melanoma%' OR attribute_value LIKE '%melanoma%')\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name IN ('CLINICAL_BENEFIT', 'DURABLE_CLINICAL_BENEFIT', 'ICI_DURABLE_CLINICAL_BENEFIT')\nORDER BY attribute_value\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check what cancer types are actually available in the study:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value, COUNT(DISTINCT sample_unique_id) as sample_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE'\nGROUP BY attribute_value\nORDER BY sample_count DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attribute_value":"Non-Small Cell Lung Cancer","sample_count":7809},{"attribute_value":"Colorectal Cancer","sample_count":5543},{"attribute_value":"Breast Cancer","sample_count":5368},{"attribute_value":"Prostate Cancer","sample_count":3211},{"attribute_value":"Pancreatic Cancer","sample_count":3109}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attribute_name, COUNT(DISTINCT sample_unique_id) as sample_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name IN ('CLINICAL_BENEFIT', 'DURABLE_CLINICAL_BENEFIT', 'ICI_DURABLE_CLINICAL_BENEFIT', 'IMMUNOTHERAPY_RESPONSE', 'BEST_RESPONSE_IMMUNOTHERAPY')\nGROUP BY attribute_name\nORDER BY sample_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check if melanoma exists in the detailed cancer types and also look at all available cancer types:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value, COUNT(DISTINCT sample_unique_id) as sample_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE_DETAILED'\nGROUP BY attribute_value\nORDER BY sample_count DESC\nLIMIT 50\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attribute_value":"Lung Adenocarcinoma","sample_count":5957},{"attribute_value":"Colon Adenocarcinoma","sample_count":3352},{"attribute_value":"Breast Invasive Ductal Carcinoma","sample_count":3350},{"attribute_value":"Prostate Adenocarcinoma","sample_count":3177},{"attribute_value":"Pancreatic Adenocarcinoma","sample_count":2703},{"attribute_value":"Rectal Adenocarcinoma","sample_count":1321},{"attribute_value":"Invasive Breast Carcinoma","sample_count":967},{"attribute_value":"Lung Squamous Cell Carcinoma","sample_count":822},{"attribute_value":"Colorectal Adenocarcinoma","sample_count":716},{"attribute_value":"Breast Invasive Lobular Carcinoma","sample_count":538},{"attribute_value":"Non-Small Cell Lung Cancer","sample_count":499},{"attribute_value":"Pancreatic Neuroendocrine Tumor","sample_count":259},{"attribute_value":"Breast Invasive Carcinoma, NOS","sample_count":215},{"attribute_value":"Large Cell Neuroendocrine Carcinoma","sample_count":134},{"attribute_value":"Breast Invasive Cancer, NOS","sample_count":130},{"attribute_value":"Mucinous Adenocarcinoma of the Colon and Rectum","sample_count":113},{"attribute_value":"Lung Carcinoid","sample_count":91},{"attribute_value":"Breast Mixed Ductal and Lobular Carcinoma","sample_count":86},{"attribute_value":"Poorly Differentiated Non-Small Cell Lung Cancer","sample_count":77},{"attribute_value":"Lung Adenosquamous Carcinoma","sample_count":56},{"attribute_value":"Adenosquamous Carcinoma of the Pancreas","sample_count":50},{"attribute_value":"Pleomorphic Carcinoma of the Lung","sample_count":45},{"attribute_value":"Atypical Lung Carcinoid","sample_count":43},{"attribute_value":"Acinar Cell Carcinoma of the Pancreas","sample_count":43},{"attribute_value":"Lung Neuroendocrine Tumor","sample_count":32},{"attribute_value":"Metaplastic Breast Cancer","sample_count":31},{"attribute_value":"Undifferentiated Carcinoma of the Pancreas","sample_count":25},{"attribute_value":"Medullary Carcinoma of the Colon","sample_count":21},{"attribute_value":"Prostate Neuroendocrine Carcinoma","sample_count":19},{"attribute_value":"Signet Ring Cell Adenocarcinoma of the Colon and Rectum","sample_count":19},{"attribute_value":"Sarcomatoid Carcinoma of the Lung","sample_count":19},{"attribute_value":"Prostate Small Cell Carcinoma","sample_count":15},{"attribute_value":"Breast Invasive Mixed Mucinous Carcinoma","sample_count":14},{"attribute_value":"Intraductal Papillary Mucinous Neoplasm","sample_count":10},{"attribute_value":"Adenoid Cystic Breast Cancer","sample_count":10},{"attribute_value":"Large Cell Lung Carcinoma","sample_count":7},{"attribute_value":"Adenoid Cystic Carcinoma of the Lung","sample_count":7},{"attribute_value":"Pancreatic Neuroendocrine Carcinoma","sample_count":7},{"attribute_value":"Breast Neoplasm, NOS","sample_count":6},{"attribute_value":"Mixed Type Metaplastic Breast Cancer","sample_count":6},{"attribute_value":"Lung Adenocarcinoma In Situ","sample_count":6},{"attribute_value":"Solid Pseudopapillary Neoplasm of the Pancreas","sample_count":5},{"attribute_value":"Lymphoepithelioma-like Carcinoma of the Lung","sample_count":5},{"attribute_value":"Spindle Cell Carcinoma of the Lung","sample_count":4},{"attribute_value":"Pancreatoblastoma","sample_count":3},{"attribute_value":"Mucinous Cystic Neoplasm","sample_count":2},{"attribute_value":"Breast Invasive Carcinosarcoma, NOS","sample_count":2},{"attribute_value":"Juvenile Secretory Carcinoma of the Breast","sample_count":2},{"attribute_value":"Adenomyoepithelioma of the Breast","sample_count":2},{"attribute_value":"Mucoepidermoid Carcinoma of the Lung","sample_count":2}]}
```


I don't see melanoma in the top cancer types. Let me search more broadly and also check what response attributes actually have data:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attribute_value, COUNT(DISTINCT sample_unique_id) as sample_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE_DETAILED'\n  AND lower(attribute_value) LIKE '%melan%'\nGROUP BY attribute_value\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attribute_name, COUNT(DISTINCT sample_unique_id) as samples_with_data\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name IN ('CLINICAL_BENEFIT', 'DURABLE_CLINICAL_BENEFIT', 'ICI_DURABLE_CLINICAL_BENEFIT', \n                          'IMMUNOTHERAPY_RESPONSE', 'BEST_RESPONSE_IMMUNOTHERAPY', 'ANY_LINE_IMMUNO',\n                          'IMMUNOTHERAPY')\n  AND attribute_value IS NOT NULL\n  AND attribute_value != ''\nGROUP BY attribute_name\nORDER BY samples_with_data DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check the actual structure of the clinical_data_derived table and see what data is available:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT COUNT(DISTINCT sample_unique_id) as total_samples,\n       COUNT(DISTINCT patient_unique_id) as total_patients\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"total_samples":25041,"total_patients":24950}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attribute_name, COUNT(*) as record_count, COUNT(DISTINCT sample_unique_id) as sample_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND (attribute_name LIKE '%IMMUNO%' OR attribute_name LIKE '%BENEFIT%' OR attribute_name LIKE '%RESPONSE%')\nGROUP BY attribute_name\nORDER BY sample_count DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


It seems the immunotherapy response data might not be in the clinical_data_derived table. Let me check the clinical_sample table directly:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT cs.attr_id, COUNT(DISTINCT cs.internal_id) as sample_count\nFROM clinical_sample cs\nJOIN sample s ON cs.internal_id = s.internal_id\nJOIN patient p ON s.patient_id = p.internal_id\nJOIN cancer_study c ON p.cancer_study_id = c.cancer_study_id\nWHERE c.cancer_study_identifier = 'msk_chord_2024'\n  AND (cs.attr_id LIKE '%IMMUNO%' OR cs.attr_id LIKE '%BENEFIT%' OR cs.attr_id LIKE '%RESPONSE%')\nGROUP BY cs.attr_id\nORDER BY sample_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check the clinical_patient table for patient-level immunotherapy response data:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT cp.attr_id, COUNT(DISTINCT cp.patient_id) as patient_count\nFROM clinical_patient cp\nJOIN patient p ON cp.patient_id = p.internal_id\nJOIN cancer_study c ON p.cancer_study_id = c.cancer_study_id\nWHERE c.cancer_study_identifier = 'msk_chord_2024'\n  AND (cp.attr_id LIKE '%IMMUNO%' OR cp.attr_id LIKE '%BENEFIT%' OR cp.attr_id LIKE '%RESPONSE%')\nGROUP BY cp.attr_id\nORDER BY patient_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"error_message":"Query execution failed: Received ClickHouse exception, code: 47, server response: Code: 47. DB::Exception: Identifier 'cp.patient_id' cannot be resolved from table with name cp. In scope SELECT cp.attr_id, COUNTDistinct(cp.patient_id) AS patient_count FROM clinical_patient AS cp INNER JOIN patient AS p ON cp.patient_id = p.internal_id INNER JOIN cancer_study AS c ON p.cancer_study_id = c.cancer_study_id WHERE (c.cancer_study_identifier = 'msk_chord_2024') AND ((cp.attr_id LIKE '%IMMUNO%') OR (cp.attr_id LIKE '%BENEFIT%') OR (cp.attr_id LIKE '%RESPONSE%')) GROUP BY cp.attr_id ORDER BY patient_count DESC. Maybe you meant: ['cp.attr_id']. (UNKNOWN_IDENTIFIER) (version 25.8.1.36912 (official build)) (for url https://dl96orhu96.us-east-1.aws.clickhouse.cloud:8443)"}
```


Let me check the structure of the clinical_patient table:



Calling `clickhouse_list_table_columns` with args:
```json
{
  "table": "clinical_patient"
}
```



Result from `clickhouse_list_table_columns`:
```json
{"columns":[{"name":"internal_id","type":"Nullable(Int64)","comment":"References patient.internal_id."},{"name":"attr_id","type":"Nullable(String)","comment":"Attribute identifier."},{"name":"attr_value","type":"Nullable(String)","comment":"Value of the clinical attribute."}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT cp.attr_id, COUNT(DISTINCT cp.internal_id) as patient_count\nFROM clinical_patient cp\nJOIN patient p ON cp.internal_id = p.internal_id\nJOIN cancer_study c ON p.cancer_study_id = c.cancer_study_id\nWHERE c.cancer_study_identifier = 'msk_chord_2024'\n  AND (cp.attr_id LIKE '%IMMUNO%' OR cp.attr_id LIKE '%BENEFIT%' OR cp.attr_id LIKE '%RESPONSE%')\nGROUP BY cp.attr_id\nORDER BY patient_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check what attributes are actually available in the clinical_attribute_meta table:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attr_id, description, patient_attribute\nFROM clinical_attribute_meta cam\nJOIN cancer_study cs ON cam.cancer_study_id = cs.cancer_study_id\nWHERE cs.cancer_study_identifier = 'msk_chord_2024'\n  AND (attr_id LIKE '%IMMUNO%' OR attr_id LIKE '%BENEFIT%' OR attr_id LIKE '%RESPONSE%' OR attr_id LIKE '%MELAN%')\nORDER BY attr_id\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check all available clinical attributes to understand what's in this study:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attr_id, description, patient_attribute\nFROM clinical_attribute_meta cam\nJOIN cancer_study cs ON cam.cancer_study_id = cs.cancer_study_id\nWHERE cs.cancer_study_identifier = 'msk_chord_2024'\nORDER BY attr_id\nLIMIT 100\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attr_id":"ADRENAL_GLANDS","description":"DESCRIPTION: History of Adrenal Gland as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"BONE","description":"DESCRIPTION: History of Bone as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"CANCER_TYPE","description":"The main cancer type as defined by the Oncotree cancer classification system for precision oncology. Source: MPath","patient_attribute":0},{"attr_id":"CANCER_TYPE_DETAILED","description":"The cancer subtype as defined by the Oncotree cancer classification system for precision oncology. Source: MPath","patient_attribute":0},{"attr_id":"CLINICAL_GROUP","description":"Clinical Group","patient_attribute":0},{"attr_id":"CLINICAL_SUMMARY","description":"Clinical Summary","patient_attribute":0},{"attr_id":"CNS_BRAIN","description":"DESCRIPTION: History of CNS/Brain as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"CURRENT_AGE_DEID","description":"DESCRIPTION: Current age (limit 89). Derived from Birthdate (RMS) ---MISSING DATA: Contact RMS Database Maintainers ---SOURCE:CDM Generated (Via IDB/RMS dates)","patient_attribute":1},{"attr_id":"DIAGNOSIS_DESCRIPTION","description":"Diagnosis Description","patient_attribute":0},{"attr_id":"ETHNICITY","description":"DESCRIPTION: Ethnicity, self-reported ---MISSING DATA: patient did not provide ---SOURCE:(IDB) (RMS)","patient_attribute":1},{"attr_id":"FRACTION_GENOME_ALTERED","description":"Fraction Genome Altered","patient_attribute":0},{"attr_id":"GENDER","description":"Gender at birth","patient_attribute":1},{"attr_id":"GENE_PANEL","description":"The gene panel or assay used used to perform targeted NGS on the sample. Source: MPath","patient_attribute":0},{"attr_id":"GLEASON_FIRST_REPORTED","description":"DESCRIPTION: Patient level summary of the 1st reported Gleason score from pathology reports. NLP used to derive ---MISSING DATA: No reported Gleason Score for patient. Rule-based NLP did not sense the word gleason any pathology reports. ---SOURCE:CDM Generated (NLP)","patient_attribute":1},{"attr_id":"GLEASON_HIGHEST_REPORTED","description":"DESCRIPTION: Patient level summary of the highest reported Gleason score from pathology reports. NLP used to derive ---MISSING DATA: No reported Gleason Score for patient. Rule-based NLP did not sense the word gleason any pathology reports. ---SOURCE:CDM Generated (NLP)","patient_attribute":1},{"attr_id":"GLEASON_SAMPLE_LEVEL","description":"DESCRIPTION: Sample summary of the Gleason score reported on the specified sample ID at the time of surgery or biopsy ---MISSING DATA: No reported Gleason Score for patient. Rule-based NLP did not sense the word gleason any pathology reports. ---SOURCE:CDM Generated (NLP)","patient_attribute":0},{"attr_id":"HER2","description":"HER2","patient_attribute":1},{"attr_id":"HISTORY_OF_PDL1","description":"DESCRIPTION: History if patient ever had a pathology specimen annotated as PD-L1 positive ---MISSING DATA: patient not tested for PD-L1 ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"HR","description":"HR","patient_attribute":1},{"attr_id":"ICD_O_HISTOLOGY_DESCRIPTION","description":"ICD-O Histology Description","patient_attribute":0},{"attr_id":"INTRA_ABDOMINAL","description":"Intra Abdominal","patient_attribute":1},{"attr_id":"LIVER","description":"DESCRIPTION: History of Liver as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"LUNG","description":"DESCRIPTION: History of Lung as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"LYMPH_NODES","description":"DESCRIPTION: History of LN as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"METASTATIC_SITE","description":"Location of profiled metastatic site","patient_attribute":0},{"attr_id":"MSI_COMMENT","description":"MSI interpretation. Source: MPath","patient_attribute":0},{"attr_id":"MSI_SCORE","description":"Microsatellite Instability (MSI) score. Source: MPath","patient_attribute":0},{"attr_id":"MSI_TYPE","description":"Directly related to MSI Score; Possible values include Stable, Instable, Indeterminate, or Do not report. Source: MPath","patient_attribute":0},{"attr_id":"MUTATION_COUNT","description":"Mutation Count","patient_attribute":0},{"attr_id":"NUM_ICDO_DX","description":"DESCRIPTION: Number of Tumor Registry Entries for patient ---MISSING DATA: No tumor registry data entered for patient ---SOURCE:CDM Generated (Via IDB/RMS dates)","patient_attribute":1},{"attr_id":"ONCOTREE_CODE","description":"The assigned Oncotree code of the sample as defined by the Oncotree cancer classification system for precision oncology.","patient_attribute":0},{"attr_id":"OS_MONTHS","description":"DESCRIPTION: Overall survival from date of first sequenced sample to date of death or last contact. If patient died before first sequencing, overall survival in months is set to '0'. If patient is alive and last contact date is before date of sequencing,overall survival in months is set to 'NA'. Derived from PT_DEATH_DTE, PLA_LAST_CONTACT_DTE and date of sequencing for first specimen sequenced for patient. ---MISSING DATA: Last contact date, sequencing date missing in RMS ---SOURCE:CDM Generated (Via IDB/RMS dates)","patient_attribute":1},{"attr_id":"OS_STATUS","description":"DESCRIPTION: The patient's survival status; is the patient alive or deceased. ---MISSING DATA: Last contact date, sequencing date missing in RMS ---SOURCE:CDM Generated (Via IDB/RMS dates)","patient_attribute":1},{"attr_id":"OTHER","description":"DESCRIPTION: History of another site as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"PATHOLOGICAL_GROUP","description":"Pathological Group","patient_attribute":0},{"attr_id":"PDL1_POSITIVE","description":"DESCRIPTION: Indication if specimen was labeled as PD-L1 positive in surgical pathology report ---MISSING DATA: Patient not tested for PD-L1 ---SOURCE:(CDM) Generated (NLP)","patient_attribute":0},{"attr_id":"PLEURA","description":"DESCRIPTION: History of Pleura as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"PRIMARY_SITE","description":"The organ sub-division term assigned to the primary tumor location of the sample. Source: MPath","patient_attribute":0},{"attr_id":"PRIOR_MED_TO_MSK","description":"DESCRIPTION: Binary indication if patient recieve anti-cancer medication prior to MSK ---MISSING DATA: Initial consult (IC) notes need to be (1) within a list of acceptable note types, (2) be within 90 days of first MSK dates if patients have multiple primaries. Note types consist of medical oncologists, radiation oncologists, surgery, inpatient services and others, as they are most likely to contain information about external treatments prior to MSK. ---SOURCE:CDM Generated (NLP)","patient_attribute":1},{"attr_id":"RACE","description":"DESCRIPTION: Race, self-reported ---MISSING DATA: patient did not provide ---SOURCE:(IDB) (RMS)","patient_attribute":1},{"attr_id":"REPRODUCTIVE_ORGANS","description":"DESCRIPTION: History of Reproductive Organs as a tumor site as indicated in radiology report impression ---MISSING DATA: No CT/PET/MRI radiology report available for patient. impression section MISSING from report. ---SOURCE:(CDM) Generated (NLP)","patient_attribute":1},{"attr_id":"SAMPLE_CLASS","description":"The sample classification (i.e., tumor, cellline, xenograph).Source: MPath","patient_attribute":0},{"attr_id":"SAMPLE_COUNT","description":"Number of Samples Per Patient","patient_attribute":1},{"attr_id":"SAMPLE_COVERAGE","description":"Sequencing coverage. Source: MPath","patient_attribute":0},{"attr_id":"SAMPLE_TYPE","description":"The type assigned to a sample (i.e., normal, primary, met, recurrence). Source: MPath","patient_attribute":0},{"attr_id":"SMOKING_PREDICTIONS_3_CLASSES","description":"DESCRIPTION: Inferred smoking history. Classes: Current/Former, Never, Unknown ---MISSING DATA: The patient might not have had a 'Smoking Status' section in their Clindoc note. Potential factor for older notes, if the formatting of the section has changed; majority are from 2015-->present. ---SOURCE:CDM Generated (NLP)","patient_attribute":1},{"attr_id":"SOMATIC_STATUS","description":"Indicates if there exists a matched normal used for tumor sample analysis. Source: MPath","patient_attribute":0},{"attr_id":"STAGE_HIGHEST_RECORDED","description":"DESCRIPTION: Highest recorded stage in tumor registry (ICD-O). Data has been aggregated from the CDM derived stage information, which bins stage in stage 1-3 and stage 4. ---MISSING DATA: Stage data not entered by admins in tumor registry ---SOURCE:CDM Generated (Via IDB/RMS dates)","patient_attribute":1},{"attr_id":"TMB_NONSYNONYMOUS","description":"TMB (nonsynonymous)","patient_attribute":0},{"attr_id":"TUMOR_PURITY","description":"Proportion of cancer cells in tumor sample. Source: MPath","patient_attribute":0}]}
```


I can see the available attributes, but I don't see immunotherapy response attributes in the clinical_attribute_meta. Let me check if there's treatment data in the clinical_event tables as mentioned in the study guide:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT ced.key\nFROM clinical_event_derived ced\nWHERE ced.cancer_study_identifier = 'msk_chord_2024'\n  AND (ced.key LIKE '%IMMUNO%' OR ced.key LIKE '%RESPONSE%' OR ced.key LIKE '%BENEFIT%')\nORDER BY ced.key\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT ced.key\nFROM clinical_event_derived ced\nWHERE ced.cancer_study_identifier = 'msk_chord_2024'\nORDER BY ced.key\nLIMIT 50\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"key":"ABDOMEN"},{"key":"AGENT"},{"key":"AJCC"},{"key":"CHEST"},{"key":"CLINICAL_GROUP"},{"key":"DX_DESCRIPTION"},{"key":"ECOG"},{"key":"FLAG_OROTOPICAL"},{"key":"GLEASON_SCORE"},{"key":"HAS_CANCER"},{"key":"HEAD"},{"key":"INFERRED_TX_PROB"},{"key":"LR_UNIT_MEASURE"},{"key":"MMR_ABSENT"},{"key":"NLP_HAS_CANCER_PROBABILITY"},{"key":"NLP_PROGRESSION_PROBABILITY"},{"key":"OTHER"},{"key":"PATH_GROUP"},{"key":"PDL1_POSITIVE"},{"key":"PELVIS"},{"key":"PRIOR_MED_TO_MSK"},{"key":"PROCEDURE_TYPE"},{"key":"PROGRESSION"},{"key":"RESULT"},{"key":"RX_INVESTIGATIVE"},{"key":"SAMPLE_ID"},{"key":"SEQ_DATE"},{"key":"SOURCE"},{"key":"SOURCE_SPECIFIC"},{"key":"STAGE_CDM_DERIVED"},{"key":"STYLE_COLOR"},{"key":"SUBTYPE"},{"key":"SUMMARY"},{"key":"TEST"},{"key":"TREATMENT_TYPE"},{"key":"TUMOR_SITE"}]}
```


Good! I can see treatment data. Now let me check if there's melanoma data and what immunotherapy treatments are available:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT COUNT(DISTINCT patient_unique_id) as melanoma_patients\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE'\n  AND lower(attribute_value) LIKE '%melanoma%'\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"melanoma_patients":0}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT attribute_value\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE'\nORDER BY attribute_value\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attribute_value":"Breast Cancer"},{"attribute_value":"Colorectal Cancer"},{"attribute_value":"Non-Small Cell Lung Cancer"},{"attribute_value":"Pancreatic Cancer"},{"attribute_value":"Prostate Cancer"}]}
```


I can see that the MSK-CHORD study only contains 5 cancer types and **melanoma is not included** in this study. The study focuses on:
- Breast Cancer
- Colorectal Cancer  
- Non-Small Cell Lung Cancer
- Pancreatic Cancer
- Prostate Cancer

Let me verify this and provide you with information about what data is available:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT \n    attribute_value as cancer_type,\n    COUNT(DISTINCT patient_unique_id) as patient_count,\n    COUNT(DISTINCT sample_unique_id) as sample_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND attribute_name = 'CANCER_TYPE'\nGROUP BY attribute_value\nORDER BY patient_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"cancer_type":"Non-Small Cell Lung Cancer","patient_count":7809,"sample_count":7809},{"cancer_type":"Colorectal Cancer","patient_count":5543,"sample_count":5543},{"cancer_type":"Breast Cancer","patient_count":5368,"sample_count":5368},{"cancer_type":"Prostate Cancer","patient_count":3211,"sample_count":3211},{"cancer_type":"Pancreatic Cancer","patient_count":3109,"sample_count":3109}]}
```


Now let me check if there are other studies in cBioPortal that contain melanoma data with immunotherapy response information:



Calling `list_studies` with args:
```json
{
  "search": "melanoma",
  "limit": 50
}
```



Result from `list_studies`:
```json

```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT DISTINCT cancer_study_identifier, name\nFROM cancer_study\nWHERE lower(name) LIKE '%melanoma%'\nORDER BY cancer_study_identifier\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"cancer_study_identifier":"desm_broad_2015","name":"Desmoplastic Melanoma (Broad Institute, Nat Genet 2015)"},{"cancer_study_identifier":"mel_dfci_2019","name":"Metastatic Melanoma (DFCI, Nature Medicine 2019)"},{"cancer_study_identifier":"mel_iatlas_riaz_nivolumab_2017","name":"Melanoma (MSK, Cell 2017) - iAtlas Harmonized"},{"cancer_study_identifier":"mel_mskimpact_2020","name":"Melanoma (MSK, Clin Cancer Res 2021)"},{"cancer_study_identifier":"mel_tsam_liang_2017","name":"Acral Melanoma (TGEN, Genome Res 2017)"},{"cancer_study_identifier":"mel_ucla_2016","name":"Metastatic Melanoma (UCLA, Cell 2016)"},{"cancer_study_identifier":"skcm_broad","name":"Skin Cutaneous Melanoma (Broad, Cell 2012)"},{"cancer_study_identifier":"skcm_broad_brafresist_2012","name":"Skin Cutaneous Melanoma(Broad, Cancer Discov 2014)"},{"cancer_study_identifier":"skcm_broad_dfarber","name":"Melanoma (Broad/Dana Farber, Nature 2012)"},{"cancer_study_identifier":"skcm_dfci_2015","name":"Metastatic Melanoma (DFCI, Science 2015)"},{"cancer_study_identifier":"skcm_mskcc_2014","name":"Melanoma (MSK, NEJM 2014)"},{"cancer_study_identifier":"skcm_tcga","name":"Skin Cutaneous Melanoma (TCGA, Firehose Legacy)"},{"cancer_study_identifier":"skcm_tcga_gdc","name":"Cutaneous Melanoma (TCGA, GDC)"},{"cancer_study_identifier":"skcm_tcga_pan_can_atlas_2018","name":"Skin Cutaneous Melanoma (TCGA, PanCancer Atlas)"},{"cancer_study_identifier":"skcm_tcga_pub_2015","name":"Melanomas (TCGA, Cell 2015)"},{"cancer_study_identifier":"skcm_vanderbilt_mskcc_2015","name":"Metastatic Melanoma (MSK, JCO Precis Oncol 2017)"},{"cancer_study_identifier":"skcm_yale","name":"Skin Cutaneous Melanoma (Yale, Nat Genet 2012)"},{"cancer_study_identifier":"um_qimr_2016","name":"Uveal Melanoma (QIMR, Oncotarget 2016)"},{"cancer_study_identifier":"um_tcga_gdc","name":"Uveal Melanoma (TCGA, GDC)"},{"cancer_study_identifier":"uvm_tcga","name":"Uveal Melanoma (TCGA, Firehose Legacy)"}]}
```


Great! There are melanoma studies available. Let me check which ones have immunotherapy response data. The most promising ones appear to be:
- mel_dfci_2019 (Metastatic Melanoma DFCI, Nature Medicine 2019)
- mel_iatlas_riaz_nivolumab_2017 (Melanoma MSK, Cell 2017 - specifically mentions nivolumab)

Let me check these studies:



Calling `get_study_guide` with args:
```json
{
  "study_id": "mel_dfci_2019"
}
```



Result from `get_study_guide`:
```json
# Study Guide: Metastatic Melanoma (DFCI, Nature Medicine 2019)

**Study ID:** `mel_dfci_2019`
**Cancer Type:** mel
**Description:** Whole-exome sequencing of 144 pre-treatment samples from 144 patients with metastatic melanoma treated with anti-PD1 ICB.

## Cohort Statistics
- **Patients:** 144
- **Samples:** 145

## Available Data Types

- **COPY_NUMBER_ALTERATION**: Putative copy-number alterations from GISTIC
- **MUTATION_EXTENDED**: Mutations
- **MRNA_EXPRESSION**: mRNA expression (RNA Seq TPM)
- **MRNA_EXPRESSION**: mRNA expression z-scores relative to diploid samples (RNA Seq TPM)
- **MRNA_EXPRESSION**: mRNA expression z-scores relative to all samples (log RNA Seq TPM)

## Gene Panels

- **WES** (Whole Exome): 144 samples â€” all genes profiled

## Available Clinical Attributes

| Attribute | Samples with Data |
|-----------|------------------|
| MUTS_SUBCLONAL | 144 |
| CANCER_TYPE_DETAILED | 144 |
| TOTAL_NEOANTIGEN | 144 |
| MUTATION_COUNT | 144 |
| SOMATIC_STATUS | 144 |
| TMB_NONSYNONYMOUS | 144 |
| PLOIDY | 144 |
| BIOPSY_SITE | 144 |
| NONSYNONYMOUS_MUTATION_COUNT | 144 |
| MUTS_CLONAL | 144 |
| CANCER_TYPE | 144 |
| TOTAL_MUTATIONS | 144 |
| PRIMARY_TYPE | 144 |
| ONCOTREE_CODE | 144 |
| BIOPSY_SITE_CATEG | 144 |
| PURITY | 144 |
| CNA_PROP | 144 |
| HISTOLOGY | 144 |
| HETEROGENEITY | 144 |
| ALKYLATING_CHEMOTHERAPY | 1 |

## Top Mutated Genes

| Gene | Altered Samples |
|------|----------------|
| TTN | 92 |
| MUC16 | 86 |
| DNAH5 | 69 |
| PCLO | 65 |
| LRP1B | 57 |
| BRAF | 56 |
| DNAH6 | 49 |
| PKHD1L1 | 48 |
| RP1 | 48 |
| MXRA5 | 48 |

## Query Tips for mel_dfci_2019

```sql
-- Get all samples in this study
SELECT DISTINCT sample_unique_id, patient_unique_id
FROM clinical_data_derived
WHERE cancer_study_identifier = 'mel_dfci_2019';

-- Get mutations for a specific gene
SELECT sample_unique_id, hugo_gene_symbol, mutation_variant, mutation_type
FROM genomic_event_derived
WHERE cancer_study_identifier = 'mel_dfci_2019'
    AND hugo_gene_symbol = 'TP53'
    AND variant_type = 'mutation';

-- Get clinical data for specific attributes
SELECT sample_unique_id, attribute_name, attribute_value
FROM clinical_data_derived
WHERE cancer_study_identifier = 'mel_dfci_2019'
    AND attribute_name IN ('CANCER_TYPE', 'SAMPLE_TYPE', 'OS_MONTHS');
```

```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attr_id, description\nFROM clinical_attribute_meta cam\nJOIN cancer_study cs ON cam.cancer_study_id = cs.cancer_study_id\nWHERE cs.cancer_study_identifier = 'mel_dfci_2019'\n  AND (attr_id LIKE '%RESPONSE%' OR attr_id LIKE '%BENEFIT%' OR attr_id LIKE '%IMMUNO%')\nORDER BY attr_id\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[]}
```


Let me check the other melanoma immunotherapy study:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT attr_id, description\nFROM clinical_attribute_meta cam\nJOIN cancer_study cs ON cam.cancer_study_id = cs.cancer_study_id\nWHERE cs.cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\nORDER BY attr_id\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attr_id":"AGE_AT_DIAGNOSIS","description":"Age At Diagnosis"},{"attr_id":"CANCER_TISSUE","description":"Original tumor tissue."},{"attr_id":"CANCER_TYPE","description":"Cancer Type"},{"attr_id":"CANCER_TYPE_DETAILED","description":"Cancer Type Detailed"},{"attr_id":"CLINICAL_BENEFIT","description":"Patients have clinical benefit when mRECIST response is different than Progressive Disease."},{"attr_id":"CLINICAL_STAGE","description":"Clinical stage of cancer."},{"attr_id":"CTA_SELF_NEOANTIGEN","description":"Non-mutated self-antigens that may be abnormally expressed in tumors. A major subset includes cancer-testis antigens (CTAs), typically restricted to germline tissues but reactivated in cancers."},{"attr_id":"ERV_NEOANTIGEN","description":"Arise from aberrant expression of endogenous retroviruses (ERVs), normally silenced genomic elements reactivated in tumors."},{"attr_id":"FUSION_NEOANTIGEN","description":"Generated when structural variants (e.g., translocations, deletions, inversions) join distant genomic loci, producing novel fusion proteins or transcripts."},{"attr_id":"GENDER","description":"Patient gender"},{"attr_id":"ICI_PATHWAY","description":"Pathway that is being targeted by the ICI treatment."},{"attr_id":"ICI_RX","description":"Drug used for the treatment. Combination therapies, where more than one drug is administered, are represented by the name of both drugs."},{"attr_id":"ICI_TARGET","description":"What is the target of the ICI drug."},{"attr_id":"INDEL_NEOANTIGEN","description":"Arise from somatic insertion or deletion mutations that create frameshifts or altered coding sequences, leading to tumor-specific peptides."},{"attr_id":"METASTASIZED","description":"Indicates whether the cancer is metastatic or not."},{"attr_id":"MUTATION_COUNT","description":"Mutation Count"},{"attr_id":"ONCOTREE_CODE","description":"Oncotree Code"},{"attr_id":"OS_MONTHS","description":"Overall Survival (Months) from start of treatment"},{"attr_id":"OS_STATUS","description":"Overall Survival Status from Start of treatment"},{"attr_id":"PRIOR_ICI_RX","description":"ICI treatment(s) administered before the ICI treatment in the study. Combination therapies, where more than one procedure occurs, are represented by the name of both treatments."},{"attr_id":"PROGRESSION","description":"Progressors are defined as patients with mRECIST of Progressive Disease."},{"attr_id":"RACE","description":"Race of the patient"},{"attr_id":"RESPONDER","description":"Responders are defined as patients with mRECIST of Partial Response or Complete Response, whereas Non-Responders are those with Progressive Disease or Stable Disease."},{"attr_id":"RESPONSE","description":"Response to treatment following modified Response Evaluation Criteria in Solid Tumors (mRECIST) guidelines."},{"attr_id":"SAMPLE_COUNT","description":"Number of Samples Per Patient"},{"attr_id":"SAMPLE_DISPLAY_NAME","description":"Sample Display Name"},{"attr_id":"SAMPLE_TREATMENT","description":"The time of sample collection in relation to the ICI treatment time. Most of the datasets collected samples Pre treatment."},{"attr_id":"SNV_NEOANTIGEN","description":"Produced by somatic single-nucleotide variants that change amino acids directly or indirectly through downstream coding effects."},{"attr_id":"SOMATIC_STATUS","description":"Somatic Status"},{"attr_id":"SPECIMEN_PRESERVATION_TYPE","description":"Indicates whether the sample is FFPE or not."},{"attr_id":"SPLICE_NEOANTIGEN","description":"Generated from abnormal splicing events such as intron retention, exon skipping, or mis-splice site usage, producing tumor-specific transcripts."},{"attr_id":"TIDE_NO_BENEFITS","description":"TIDE prediction of benefit to ICI treatment."},{"attr_id":"TIDE_RESPONDER","description":"TIDE prediction of response to ICI treatment."},{"attr_id":"TISSUE_SUBTYPE","description":"Original tumor tissue subtype."},{"attr_id":"TMB_NONSYNONYMOUS","description":"TMB (nonsynonymous)"},{"attr_id":"VIRUS_NEOANTIGEN","description":"Derived from proteins encoded by oncogenic viruses (e.g., HPV, EBV, HTLV-1, HCV) that contribute to cancer development in infected tissues."}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT cs.cancer_study_identifier, cs.name, cs.description\nFROM cancer_study cs\nWHERE cs.cancer_study_identifier IN ('mel_dfci_2019', 'mel_iatlas_riaz_nivolumab_2017', 'skcm_dfci_2015')\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"cancer_study_identifier":"mel_dfci_2019","name":"Metastatic Melanoma (DFCI, Nature Medicine 2019)","description":"Whole-exome sequencing of 144 pre-treatment samples from 144 patients with metastatic melanoma treated with anti-PD1 ICB."},{"cancer_study_identifier":"skcm_dfci_2015","name":"Metastatic Melanoma (DFCI, Science 2015)","description":"Whole-exome sequencing of 110 metastatic melanoma tumor-normal pairs."},{"cancer_study_identifier":"mel_iatlas_riaz_nivolumab_2017","name":"Melanoma (MSK, Cell 2017) - iAtlas Harmonized","description":"Whole-exome sequencing and neoantigen landscape analysis of tumors from 64 advanced melanoma patients, profiled before and after nivolumab treatment. The reprocessing of raw sequencing data is coordinated by <a href=\"https://cri-iatlas.org/\">CRI iAtlas</a>."}]}
```


Perfect! The **mel_iatlas_riaz_nivolumab_2017** study has excellent immunotherapy response data. Let me analyze the genomic alterations associated with immunotherapy response in this melanoma cohort:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Get response distribution\nSELECT \n    attribute_value as response,\n    COUNT(DISTINCT patient_unique_id) as patient_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n  AND attribute_name = 'RESPONSE'\nGROUP BY attribute_value\nORDER BY patient_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"response":"Progressive Disease","patient_count":26},{"response":"Stable Disease","patient_count":19},{"patient_count":8},{"response":"Partial Response","patient_count":8},{"response":"Complete Response","patient_count":3}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Get responder vs non-responder distribution\nSELECT \n    attribute_value as responder_status,\n    COUNT(DISTINCT patient_unique_id) as patient_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n  AND attribute_name = 'RESPONDER'\nGROUP BY attribute_value\nORDER BY patient_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"responder_status":"False","patient_count":45},{"responder_status":"True","patient_count":11},{"patient_count":8}]}
```


Now let me analyze the most frequently mutated genes in responders vs non-responders:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Top mutated genes in responders vs non-responders\nWITH responder_status AS (\n    SELECT DISTINCT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n),\ngene_mutations AS (\n    SELECT \n        g.patient_unique_id,\n        g.hugo_gene_symbol,\n        r.is_responder\n    FROM genomic_event_derived g\n    JOIN responder_status r ON g.patient_unique_id = r.patient_unique_id\n    WHERE g.cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND g.variant_type = 'mutation'\n)\nSELECT \n    hugo_gene_symbol,\n    COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) as responders_mutated,\n    COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) as non_responders_mutated,\n    COUNT(DISTINCT patient_unique_id) as total_mutated,\n    round(COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) * 100.0 / 11, 2) as pct_responders,\n    round(COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) * 100.0 / 45, 2) as pct_non_responders\nFROM gene_mutations\nGROUP BY hugo_gene_symbol\nHAVING total_mutated >= 3\nORDER BY total_mutated DESC\nLIMIT 30\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"hugo_gene_symbol":"TTN","responders_mutated":7,"non_responders_mutated":19,"total_mutated":26,"pct_responders":63.64,"pct_non_responders":42.22},{"hugo_gene_symbol":"MUC16","responders_mutated":7,"non_responders_mutated":19,"total_mutated":26,"pct_responders":63.64,"pct_non_responders":42.22},{"hugo_gene_symbol":"BRAF","responders_mutated":5,"non_responders_mutated":13,"total_mutated":18,"pct_responders":45.45,"pct_non_responders":28.89},{"hugo_gene_symbol":"PCLO","responders_mutated":4,"non_responders_mutated":12,"total_mutated":16,"pct_responders":36.36,"pct_non_responders":26.67},{"hugo_gene_symbol":"CSMD1","responders_mutated":5,"non_responders_mutated":9,"total_mutated":14,"pct_responders":45.45,"pct_non_responders":20.0},{"hugo_gene_symbol":"DNAH5","responders_mutated":2,"non_responders_mutated":12,"total_mutated":14,"pct_responders":18.18,"pct_non_responders":26.67},{"hugo_gene_symbol":"FAT3","responders_mutated":4,"non_responders_mutated":9,"total_mutated":13,"pct_responders":36.36,"pct_non_responders":20.0},{"hugo_gene_symbol":"LRP1B","responders_mutated":4,"non_responders_mutated":9,"total_mutated":13,"pct_responders":36.36,"pct_non_responders":20.0},{"hugo_gene_symbol":"OBSCN","responders_mutated":2,"non_responders_mutated":11,"total_mutated":13,"pct_responders":18.18,"pct_non_responders":24.44},{"hugo_gene_symbol":"NRAS","responders_mutated":2,"non_responders_mutated":11,"total_mutated":13,"pct_responders":18.18,"pct_non_responders":24.44},{"hugo_gene_symbol":"DNAH8","responders_mutated":3,"non_responders_mutated":9,"total_mutated":12,"pct_responders":27.27,"pct_non_responders":20.0},{"hugo_gene_symbol":"PKHD1L1","responders_mutated":2,"non_responders_mutated":10,"total_mutated":12,"pct_responders":18.18,"pct_non_responders":22.22},{"hugo_gene_symbol":"ANK3","responders_mutated":3,"non_responders_mutated":9,"total_mutated":12,"pct_responders":27.27,"pct_non_responders":20.0},{"hugo_gene_symbol":"CACNA1A","responders_mutated":4,"non_responders_mutated":8,"total_mutated":12,"pct_responders":36.36,"pct_non_responders":17.78},{"hugo_gene_symbol":"ZFHX4","responders_mutated":2,"non_responders_mutated":10,"total_mutated":12,"pct_responders":18.18,"pct_non_responders":22.22},{"hugo_gene_symbol":"DSP","responders_mutated":2,"non_responders_mutated":9,"total_mutated":11,"pct_responders":18.18,"pct_non_responders":20.0},{"hugo_gene_symbol":"FLG","responders_mutated":2,"non_responders_mutated":9,"total_mutated":11,"pct_responders":18.18,"pct_non_responders":20.0},{"hugo_gene_symbol":"MUC17","responders_mutated":3,"non_responders_mutated":8,"total_mutated":11,"pct_responders":27.27,"pct_non_responders":17.78},{"hugo_gene_symbol":"USH2A","responders_mutated":4,"non_responders_mutated":7,"total_mutated":11,"pct_responders":36.36,"pct_non_responders":15.56},{"hugo_gene_symbol":"MXRA5","responders_mutated":2,"non_responders_mutated":9,"total_mutated":11,"pct_responders":18.18,"pct_non_responders":20.0},{"hugo_gene_symbol":"MROH2B","responders_mutated":1,"non_responders_mutated":10,"total_mutated":11,"pct_responders":9.09,"pct_non_responders":22.22},{"hugo_gene_symbol":"ADGRV1","responders_mutated":2,"non_responders_mutated":9,"total_mutated":11,"pct_responders":18.18,"pct_non_responders":20.0},{"hugo_gene_symbol":"COL6A3","responders_mutated":1,"non_responders_mutated":10,"total_mutated":11,"pct_responders":9.09,"pct_non_responders":22.22},{"hugo_gene_symbol":"DSCAM","responders_mutated":4,"non_responders_mutated":7,"total_mutated":11,"pct_responders":36.36,"pct_non_responders":15.56},{"hugo_gene_symbol":"CSMD2","responders_mutated":2,"non_responders_mutated":9,"total_mutated":11,"pct_responders":18.18,"pct_non_responders":20.0},{"hugo_gene_symbol":"ASXL3","responders_mutated":1,"non_responders_mutated":9,"total_mutated":10,"pct_responders":9.09,"pct_non_responders":20.0},{"hugo_gene_symbol":"SPTA1","responders_mutated":4,"non_responders_mutated":6,"total_mutated":10,"pct_responders":36.36,"pct_non_responders":13.33},{"hugo_gene_symbol":"WDFY4","responders_mutated":0,"non_responders_mutated":10,"total_mutated":10,"pct_responders":0.0,"pct_non_responders":22.22},{"hugo_gene_symbol":"AXDND1","responders_mutated":2,"non_responders_mutated":8,"total_mutated":10,"pct_responders":18.18,"pct_non_responders":17.78},{"hugo_gene_symbol":"RP1","responders_mutated":4,"non_responders_mutated":6,"total_mutated":10,"pct_responders":36.36,"pct_non_responders":13.33}]}
```


Now let me look at TMB (tumor mutational burden) and other key biomarkers:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- TMB comparison between responders and non-responders\nWITH responder_data AS (\n    SELECT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n),\ntmb_data AS (\n    SELECT \n        patient_unique_id,\n        CAST(attribute_value AS Float64) as tmb\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'TMB_NONSYNONYMOUS'\n      AND attribute_value != ''\n)\nSELECT \n    r.is_responder,\n    COUNT(DISTINCT r.patient_unique_id) as patient_count,\n    round(avg(t.tmb), 2) as mean_tmb,\n    round(median(t.tmb), 2) as median_tmb,\n    round(min(t.tmb), 2) as min_tmb,\n    round(max(t.tmb), 2) as max_tmb\nFROM responder_data r\nLEFT JOIN tmb_data t ON r.patient_unique_id = t.patient_unique_id\nGROUP BY r.is_responder\nORDER BY r.is_responder DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"is_responder":"True","patient_count":11,"mean_tmb":6.12,"median_tmb":3.92,"min_tmb":0.0,"max_tmb":28.2},{"is_responder":"False","patient_count":45,"mean_tmb":8.1,"median_tmb":3.28,"min_tmb":0.0,"max_tmb":87.3}]}
```




Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Mutation count comparison\nWITH responder_data AS (\n    SELECT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n),\nmut_count_data AS (\n    SELECT \n        patient_unique_id,\n        CAST(attribute_value AS Int64) as mutation_count\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'MUTATION_COUNT'\n      AND attribute_value != ''\n)\nSELECT \n    r.is_responder,\n    COUNT(DISTINCT r.patient_unique_id) as patient_count,\n    round(avg(m.mutation_count), 2) as mean_mutations,\n    round(median(m.mutation_count), 2) as median_mutations,\n    min(m.mutation_count) as min_mutations,\n    max(m.mutation_count) as max_mutations\nFROM responder_data r\nLEFT JOIN mut_count_data m ON r.patient_unique_id = m.patient_unique_id\nGROUP BY r.is_responder\nORDER BY r.is_responder DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"is_responder":"True","patient_count":11,"mean_mutations":183.78,"median_mutations":117.5,"min_mutations":0,"max_mutations":846},{"is_responder":"False","patient_count":45,"mean_mutations":243.48,"median_mutations":99.5,"min_mutations":0,"max_mutations":2619}]}
```


Now let me look at specific genes of interest in melanoma immunotherapy:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Key melanoma genes and immunotherapy response\nWITH responder_status AS (\n    SELECT DISTINCT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n)\nSELECT \n    g.hugo_gene_symbol,\n    COUNT(DISTINCT CASE WHEN r.is_responder = 'True' THEN g.patient_unique_id END) as responders_mutated,\n    COUNT(DISTINCT CASE WHEN r.is_responder = 'False' THEN g.patient_unique_id END) as non_responders_mutated,\n    round(COUNT(DISTINCT CASE WHEN r.is_responder = 'True' THEN g.patient_unique_id END) * 100.0 / 11, 2) as pct_responders,\n    round(COUNT(DISTINCT CASE WHEN r.is_responder = 'False' THEN g.patient_unique_id END) * 100.0 / 45, 2) as pct_non_responders\nFROM genomic_event_derived g\nJOIN responder_status r ON g.patient_unique_id = r.patient_unique_id\nWHERE g.cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n  AND g.variant_type = 'mutation'\n  AND g.hugo_gene_symbol IN ('BRAF', 'NRAS', 'NF1', 'TP53', 'CDKN2A', 'PTEN', 'ARID2', 'DDX3X', \n                               'JAK1', 'JAK2', 'B2M', 'HLA-A', 'HLA-B', 'HLA-C', 'SERPINB3', 'SERPINB4')\nGROUP BY g.hugo_gene_symbol\nORDER BY (responders_mutated + non_responders_mutated) DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"hugo_gene_symbol":"BRAF","responders_mutated":5,"non_responders_mutated":13,"pct_responders":45.45,"pct_non_responders":28.89},{"hugo_gene_symbol":"NRAS","responders_mutated":2,"non_responders_mutated":11,"pct_responders":18.18,"pct_non_responders":24.44},{"hugo_gene_symbol":"CDKN2A","responders_mutated":2,"non_responders_mutated":4,"pct_responders":18.18,"pct_non_responders":8.89},{"hugo_gene_symbol":"TP53","responders_mutated":2,"non_responders_mutated":2,"pct_responders":18.18,"pct_non_responders":4.44},{"hugo_gene_symbol":"NF1","responders_mutated":1,"non_responders_mutated":2,"pct_responders":9.09,"pct_non_responders":4.44},{"hugo_gene_symbol":"SERPINB3","responders_mutated":0,"non_responders_mutated":3,"pct_responders":0.0,"pct_non_responders":6.67},{"hugo_gene_symbol":"PTEN","responders_mutated":1,"non_responders_mutated":2,"pct_responders":9.09,"pct_non_responders":4.44},{"hugo_gene_symbol":"ARID2","responders_mutated":0,"non_responders_mutated":3,"pct_responders":0.0,"pct_non_responders":6.67},{"hugo_gene_symbol":"SERPINB4","responders_mutated":0,"non_responders_mutated":2,"pct_responders":0.0,"pct_non_responders":4.44},{"hugo_gene_symbol":"JAK2","responders_mutated":1,"non_responders_mutated":0,"pct_responders":9.09,"pct_non_responders":0.0}]}
```


Let me also check for copy number alterations and neoantigen data:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Neoantigen burden comparison\nWITH responder_data AS (\n    SELECT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n)\nSELECT \n    cd.attribute_name,\n    r.is_responder,\n    COUNT(DISTINCT r.patient_unique_id) as patient_count,\n    round(avg(CAST(cd.attribute_value AS Float64)), 2) as mean_value,\n    round(median(CAST(cd.attribute_value AS Float64)), 2) as median_value\nFROM responder_data r\nLEFT JOIN clinical_data_derived cd ON r.patient_unique_id = cd.patient_unique_id\nWHERE cd.cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n  AND cd.attribute_name IN ('SNV_NEOANTIGEN', 'INDEL_NEOANTIGEN', 'FUSION_NEOANTIGEN', \n                             'SPLICE_NEOANTIGEN', 'CTA_SELF_NEOANTIGEN')\n  AND cd.attribute_value != ''\nGROUP BY cd.attribute_name, r.is_responder\nORDER BY cd.attribute_name, r.is_responder DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"attribute_name":"CTA_SELF_NEOANTIGEN","is_responder":"True","patient_count":10,"mean_value":8.18,"median_value":6.0},{"attribute_name":"CTA_SELF_NEOANTIGEN","is_responder":"False","patient_count":36,"mean_value":7.94,"median_value":6.0},{"attribute_name":"FUSION_NEOANTIGEN","is_responder":"True","patient_count":10,"mean_value":1.29,"median_value":1.0},{"attribute_name":"FUSION_NEOANTIGEN","is_responder":"False","patient_count":36,"mean_value":1.23,"median_value":1.0},{"attribute_name":"INDEL_NEOANTIGEN","is_responder":"True","patient_count":10,"mean_value":1.0,"median_value":1.0},{"attribute_name":"INDEL_NEOANTIGEN","is_responder":"False","patient_count":36,"mean_value":1.13,"median_value":1.0},{"attribute_name":"SNV_NEOANTIGEN","is_responder":"True","patient_count":10,"mean_value":29.53,"median_value":11.0},{"attribute_name":"SNV_NEOANTIGEN","is_responder":"False","patient_count":36,"mean_value":58.72,"median_value":21.0},{"attribute_name":"SPLICE_NEOANTIGEN","is_responder":"True","patient_count":10,"mean_value":8.18,"median_value":8.0},{"attribute_name":"SPLICE_NEOANTIGEN","is_responder":"False","patient_count":36,"mean_value":8.79,"median_value":5.0}]}
```


Now let me check for genes enriched in responders specifically:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Genes more frequently mutated in responders\nWITH responder_status AS (\n    SELECT DISTINCT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n),\ngene_mutations AS (\n    SELECT \n        g.patient_unique_id,\n        g.hugo_gene_symbol,\n        r.is_responder\n    FROM genomic_event_derived g\n    JOIN responder_status r ON g.patient_unique_id = r.patient_unique_id\n    WHERE g.cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND g.variant_type = 'mutation'\n)\nSELECT \n    hugo_gene_symbol,\n    COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) as responders_mutated,\n    COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) as non_responders_mutated,\n    round(COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) * 100.0 / 11, 2) as pct_responders,\n    round(COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) * 100.0 / 45, 2) as pct_non_responders,\n    round((COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) * 100.0 / 11) - \n          (COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) * 100.0 / 45), 2) as enrichment_in_responders\nFROM gene_mutations\nGROUP BY hugo_gene_symbol\nHAVING responders_mutated >= 3\nORDER BY enrichment_in_responders DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"hugo_gene_symbol":"DNAH6","responders_mutated":5,"non_responders_mutated":4,"pct_responders":45.45,"pct_non_responders":8.89,"enrichment_in_responders":36.57},{"hugo_gene_symbol":"PEG3","responders_mutated":5,"non_responders_mutated":5,"pct_responders":45.45,"pct_non_responders":11.11,"enrichment_in_responders":34.34},{"hugo_gene_symbol":"COL21A1","responders_mutated":4,"non_responders_mutated":2,"pct_responders":36.36,"pct_non_responders":4.44,"enrichment_in_responders":31.92},{"hugo_gene_symbol":"ADGRB3","responders_mutated":4,"non_responders_mutated":2,"pct_responders":36.36,"pct_non_responders":4.44,"enrichment_in_responders":31.92},{"hugo_gene_symbol":"NBEA","responders_mutated":4,"non_responders_mutated":3,"pct_responders":36.36,"pct_non_responders":6.67,"enrichment_in_responders":29.7},{"hugo_gene_symbol":"DOCK3","responders_mutated":4,"non_responders_mutated":4,"pct_responders":36.36,"pct_non_responders":8.89,"enrichment_in_responders":27.47},{"hugo_gene_symbol":"TENM2","responders_mutated":4,"non_responders_mutated":4,"pct_responders":36.36,"pct_non_responders":8.89,"enrichment_in_responders":27.47},{"hugo_gene_symbol":"LRP2","responders_mutated":4,"non_responders_mutated":4,"pct_responders":36.36,"pct_non_responders":8.89,"enrichment_in_responders":27.47},{"hugo_gene_symbol":"SPHKAP","responders_mutated":4,"non_responders_mutated":4,"pct_responders":36.36,"pct_non_responders":8.89,"enrichment_in_responders":27.47},{"hugo_gene_symbol":"POTEC","responders_mutated":3,"non_responders_mutated":0,"pct_responders":27.27,"pct_non_responders":0.0,"enrichment_in_responders":27.27},{"hugo_gene_symbol":"LARGE1","responders_mutated":3,"non_responders_mutated":0,"pct_responders":27.27,"pct_non_responders":0.0,"enrichment_in_responders":27.27},{"hugo_gene_symbol":"CSMD1","responders_mutated":5,"non_responders_mutated":9,"pct_responders":45.45,"pct_non_responders":20.0,"enrichment_in_responders":25.45},{"hugo_gene_symbol":"DNAH7","responders_mutated":4,"non_responders_mutated":5,"pct_responders":36.36,"pct_non_responders":11.11,"enrichment_in_responders":25.25},{"hugo_gene_symbol":"ZDBF2","responders_mutated":3,"non_responders_mutated":1,"pct_responders":27.27,"pct_non_responders":2.22,"enrichment_in_responders":25.05},{"hugo_gene_symbol":"COL28A1","responders_mutated":3,"non_responders_mutated":1,"pct_responders":27.27,"pct_non_responders":2.22,"enrichment_in_responders":25.05},{"hugo_gene_symbol":"ITGA1","responders_mutated":3,"non_responders_mutated":1,"pct_responders":27.27,"pct_non_responders":2.22,"enrichment_in_responders":25.05},{"hugo_gene_symbol":"FMO3","responders_mutated":3,"non_responders_mutated":1,"pct_responders":27.27,"pct_non_responders":2.22,"enrichment_in_responders":25.05},{"hugo_gene_symbol":"TRIM29","responders_mutated":3,"non_responders_mutated":1,"pct_responders":27.27,"pct_non_responders":2.22,"enrichment_in_responders":25.05},{"hugo_gene_symbol":"FLT1","responders_mutated":3,"non_responders_mutated":1,"pct_responders":27.27,"pct_non_responders":2.22,"enrichment_in_responders":25.05},{"hugo_gene_symbol":"RP1","responders_mutated":4,"non_responders_mutated":6,"pct_responders":36.36,"pct_non_responders":13.33,"enrichment_in_responders":23.03}]}
```


Now let me check genes enriched in non-responders (resistance markers):



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Genes more frequently mutated in non-responders (resistance markers)\nWITH responder_status AS (\n    SELECT DISTINCT \n        patient_unique_id,\n        attribute_value as is_responder\n    FROM clinical_data_derived\n    WHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND attribute_name = 'RESPONDER'\n      AND attribute_value IN ('True', 'False')\n),\ngene_mutations AS (\n    SELECT \n        g.patient_unique_id,\n        g.hugo_gene_symbol,\n        r.is_responder\n    FROM genomic_event_derived g\n    JOIN responder_status r ON g.patient_unique_id = r.patient_unique_id\n    WHERE g.cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n      AND g.variant_type = 'mutation'\n)\nSELECT \n    hugo_gene_symbol,\n    COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) as responders_mutated,\n    COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) as non_responders_mutated,\n    round(COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) * 100.0 / 11, 2) as pct_responders,\n    round(COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) * 100.0 / 45, 2) as pct_non_responders,\n    round((COUNT(DISTINCT CASE WHEN is_responder = 'False' THEN patient_unique_id END) * 100.0 / 45) - \n          (COUNT(DISTINCT CASE WHEN is_responder = 'True' THEN patient_unique_id END) * 100.0 / 11), 2) as enrichment_in_non_responders\nFROM gene_mutations\nGROUP BY hugo_gene_symbol\nHAVING non_responders_mutated >= 5\nORDER BY enrichment_in_non_responders DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"hugo_gene_symbol":"WDFY4","responders_mutated":0,"non_responders_mutated":10,"pct_responders":0.0,"pct_non_responders":22.22,"enrichment_in_non_responders":22.22},{"hugo_gene_symbol":"BRINP3","responders_mutated":0,"non_responders_mutated":9,"pct_responders":0.0,"pct_non_responders":20.0,"enrichment_in_non_responders":20.0},{"hugo_gene_symbol":"AHNAK2","responders_mutated":0,"non_responders_mutated":9,"pct_responders":0.0,"pct_non_responders":20.0,"enrichment_in_non_responders":20.0},{"hugo_gene_symbol":"HCN1","responders_mutated":0,"non_responders_mutated":8,"pct_responders":0.0,"pct_non_responders":17.78,"enrichment_in_non_responders":17.78},{"hugo_gene_symbol":"SLC9A2","responders_mutated":0,"non_responders_mutated":7,"pct_responders":0.0,"pct_non_responders":15.56,"enrichment_in_non_responders":15.56},{"hugo_gene_symbol":"CPXM2","responders_mutated":0,"non_responders_mutated":7,"pct_responders":0.0,"pct_non_responders":15.56,"enrichment_in_non_responders":15.56},{"hugo_gene_symbol":"LAMA5","responders_mutated":0,"non_responders_mutated":7,"pct_responders":0.0,"pct_non_responders":15.56,"enrichment_in_non_responders":15.56},{"hugo_gene_symbol":"MUC5AC","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"ATXN2","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"NPAP1","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"COL4A2","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"PTPRQ","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"DNAH2","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"FAT2","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"FGD3","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"COL4A4","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"SCN1A","responders_mutated":0,"non_responders_mutated":6,"pct_responders":0.0,"pct_non_responders":13.33,"enrichment_in_non_responders":13.33},{"hugo_gene_symbol":"COL6A3","responders_mutated":1,"non_responders_mutated":10,"pct_responders":9.09,"pct_non_responders":22.22,"enrichment_in_non_responders":13.13},{"hugo_gene_symbol":"MROH2B","responders_mutated":1,"non_responders_mutated":10,"pct_responders":9.09,"pct_non_responders":22.22,"enrichment_in_non_responders":13.13},{"hugo_gene_symbol":"RNF213","responders_mutated":0,"non_responders_mutated":5,"pct_responders":0.0,"pct_non_responders":11.11,"enrichment_in_non_responders":11.11}]}
```


Perfect! Now let me create a comprehensive summary. Let me also check the clinical benefit attribute:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\n-- Clinical benefit distribution\nSELECT \n    attribute_value as clinical_benefit,\n    COUNT(DISTINCT patient_unique_id) as patient_count\nFROM clinical_data_derived\nWHERE cancer_study_identifier = 'mel_iatlas_riaz_nivolumab_2017'\n  AND attribute_name = 'CLINICAL_BENEFIT'\nGROUP BY attribute_value\nORDER BY patient_count DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"clinical_benefit":"True","patient_count":30},{"clinical_benefit":"False","patient_count":26},{"patient_count":8}]}
```


## Summary

I need to clarify an important finding: **The MSK-CHORD study (msk_chord_2024) does not include melanoma patients**. The study only contains data for:
- Non-Small Cell Lung Cancer (7,809 patients)
- Colorectal Cancer (5,543 patients)
- Breast Cancer (5,368 patients)
- Prostate Cancer (3,211 patients)
- Pancreatic Cancer (3,109 patients)

However, I found excellent melanoma immunotherapy data in the **Melanoma (MSK, Cell 2017) study** (`mel_iatlas_riaz_nivolumab_2017`), which contains 64 advanced melanoma patients treated with nivolumab (anti-PD1 immunotherapy).

## Genomic Alterations Associated with Immunotherapy Response in Melanoma

### Study Overview
- **Study**: Melanoma (MSK, Cell 2017) - iAtlas Harmonized
- **Treatment**: Nivolumab (anti-PD1)
- **Patients**: 64 advanced melanoma patients
- **Response Classification**: 
  - Responders (CR/PR): 11 patients (17%)
  - Non-responders (SD/PD): 45 patients (70%)
  - Unknown: 8 patients (13%)

### Key Findings:

#### 1. **Tumor Mutational Burden (TMB)**
- **Responders**: Mean TMB = 6.12, Median = 3.92
- **Non-responders**: Mean TMB = 8.10, Median = 3.28
- Surprisingly, TMB was not significantly higher in responders, suggesting other factors are more important

#### 2. **Mutation Count**
- **Responders**: Mean = 184 mutations, Median = 118
- **Non-responders**: Mean = 243 mutations, Median = 100

#### 3. **Driver Gene Mutations**

**BRAF** (most common driver):
- Responders: 45.5% (5/11)
- Non-responders: 28.9% (13/45)
- **Higher in responders**, suggesting BRAF mutations may predict better response

**NRAS**:
- Responders: 18.2% (2/11)
- Non-responders: 24.4% (11/45)
- Slightly enriched in non-responders

**Other key genes**:
- **CDKN2A**: 18.2% responders vs 8.9% non-responders
- **TP53**: 18.2% responders vs 4.4% non-responders
- **JAK2**: 9.1% responders vs 0% non-responders (potential response marker)

#### 4. **Genes Enriched in Responders** (Potential Predictive Biomarkers)

| Gene | Responders | Non-responders | Enrichment |
|------|------------|----------------|------------|
| **DNAH6** | 45.5% | 8.9% | +36.6% |
| **PEG3** | 45.5% | 11.1% | +34.3% |
| **COL21A1** | 36.4% | 4.4% | +31.9% |
| **ADGRB3** | 36.4% | 4.4% | +31.9% |
| **NBEA** | 36.4% | 6.7% | +29.7% |
| **CSMD1** | 45.5% | 20.0% | +25.5% |
| **BRAF** | 45.5% | 28.9% | +16.6% |

#### 5. **Genes Enriched in Non-responders** (Resistance Markers)

| Gene | Non-responders | Responders | Enrichment |
|------|----------------|------------|------------|
| **WDFY4** | 22.2% | 0% | +22.2% |
| **BRINP3** | 20.0% | 0% | +20.0% |
| **AHNAK2** | 20.0

---

## Model Information
**Model:** anthropic:claude-sonnet-4-5-20250929
**Provider:** Anthropic
**Max Tokens:** 4096

---

*Generated on 2026-01-28 12:23:50*